Zimmer Biomet to Acquire Paragon 28 in $1.2 Billion Deal
Zimmer Biomet Holdings ( ZBH, Financials) has entered into an agreement to acquire Paragon 28 ( FNA, Financials) for approximately $1.2 billion, including an equity value of $1.1 billion. Worth around $5 billion, the agreement broadens Zimmer Biomet's portfolio into the foot and ankle market.
Zimmer Biomet (NYSE:ZBH – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Needham & Company LLC in a research note issued to investors on Wednesday,Benzinga reports.
Zimmer Biomet Holdings Inc (NYSE:ZBH), a leading player in the medical devices sector with a market capitalization of $22.12 ...
Bank of America Securities analyst Travis Steed has maintained their neutral stance on ZBH stock, giving a Hold rating today.Invest with ...
Zimmer Biomet is taking steps to expand its foot and ankle orthopedics business with a $1.1 billion deal to acquire ...
Fifth Third Bancorp lessened its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 2.5% in the fourth ...
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), ...
Zimmer Biomet Holdings Inc. closed 15.92% short of its 52-week high of $133.90, which the company achieved on March 28th.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback